In a groundbreaking collaboration with C-MET, Lord's Mark Industries Limited is making strides in breast cancer screening technology. Utili...

Bharat Biotech is “back in action” after a two-year post-Covid reset, founder Krishna Ella says, with the company expanding beyond vaccines...

Ichor Biologics is seeking eighty to one hundred million dollars from private equity investors. The Hyderabad-based company operates in the...

Facing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...

The Union health ministry issued an advisory against unregulated stem cell therapies. Therapeutic use of stem cells for autism is restricte...

The Union Health Ministry has tightened oversight of stem cell therapies, warning against their unregulated use and making clear that they ...

The Supreme Court dismissed the Union government's challenge to a High Court judgment. This ruling clarified jurisdiction over drug regulat...

India's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...

India's government plans to streamline drug approval processes for domestic use. Applicants can now start studies after intimating the drug...

Manipal Health Enterprises plans significant expansion across several Indian states. The company is adopting a digital-physical healthcare ...

Top Indian health institutions are partnering with the Armed Forces Medical Services. These collaborations focus on developing advanced med...

Private equity firm ChrysCapital is set to acquire a significant stake in Linux Laboratories. This deal will see existing investor Tata Cap...

Piyush Goyal emphasized the importance of enhancing India's pharmaceutical industry to draw in more investments. He urged for the creation ...

India's drug regulator has cleared the path for local lenacapavir manufacturing. Two Indian pharmaceutical companies received waivers for l...

India's research funding system suffers a staggering ₹3,000 crore in losses each year due to overlapping grants. Implementing a unified tra...

The Supreme Court ruled that state execution powers are not arbitrary. The method of execution must uphold human dignity and minimize suffe...

India’s drug regulator has clarified that new drugs not approved anywhere globally must undergo the full domestic regulatory process, even ...